ERNEST MARIO
CIK 1180469 · last filed 2024-06-10
ERNEST MARIO is a corporate insider who has filed 301 SEC Form 4 insider transactions across 15 companies since 2007. The most recent filing, for SLNO, was dated Jun 10, 2024. Across all open-market trades the lifetime net is −$44.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.7M across reported positions. 64 SEC filings were submitted jointly with CELGENE CORP /DE/.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.71M
15
301
-$44.39M
Filer Profile
P.O. BOX 445
CHATHAM, NJ 07928
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC (SLNO) Delisted | Director | 214,855 | $53.01 | $11.39M | $0 | 20 | 2024-06-10 |
| HYPERION DEFI, INC. (EYEN) Delisted | Director | 4,784 | $15.82 | $75.7K | $1.19M | 8 | 2021-11-22 |
| Kindred Biosciences, Inc. (KIN) Delisted | Director | 125,000 | $9.25 | $1.16M | $387.0K | 14 | 2021-01-22 |
| CELGENE CORP /DE/ (CELGZ) Delisted | Director | 0 | — | — | -$26.01M | 51 | 2019-11-22 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | Director | 471,218 | — | — | $0 | 12 | 2019-06-12 |
| TNXP | Director | 0 | $12.28 | $0 | $1.03M | 30 | 2018-06-27 |
| CHIMERIX INC (CMRX) Delisted | Director | 121,072 | $8.54 | $1.03M | $1.22M | 36 | 2018-05-21 |
| SOLENO THERAPEUTICS INC (CAPNW) Delisted | Director | 1,795,929 | — | — | $0 | 2 | 2017-05-09 |
| SOLENO THERAPEUTICS INC (CAPN.W) Delisted | Director | 1,789,678 | — | — | $522.7K | 20 | 2016-10-11 |
| BSX | Director | 86,032 | $43.10 | $3.71M | -$4.09M | 47 | 2015-11-17 |
| XENOPORT INC (XNPT) Delisted | Director | 88,750 | — | — | $194.8K | 6 | 2015-05-21 |
| VIVUS INC (VVUS) Delisted | Director | 8,112 | — | — | $758.9K | 5 | 2013-05-30 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Director | 0 | — | — | -$20.28M | 31 | 2011-12-06 |
| CELGENE CORP /DE/ (CELG) Delisted | Director | 46,370 | — | — | $687.4K | 9 | 2010-06-18 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | Director | 1,818 | — | — | $0 | 2 | 2007-07-26 |
Recent Filings
301 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-10 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Grant (A) | +6,500 | $0 | EDGAR |
| 2024-05-23 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Exer (X) | +62,000 | $279.0K | EDGAR |
| 2024-01-10 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Gift (G) | −3,523 | $0 | EDGAR |
| 2023-12-04 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Gift (G) | −8,700 | $0 | EDGAR |
| 2023-05-26 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-10-14 | SOLENO THERAPEUTICS INC (SLNO) Delisted | — | — | $0 | EDGAR |
| 2022-10-14 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Buy (P) | +1,860,000 | $0 | EDGAR |
| 2022-02-02 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Grant (A) | +56,338 | $20.0K | EDGAR |
| 2021-11-22 | HYPERION DEFI, INC. (EYEN) Delisted | Grant (A) | +6,963 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.